Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Recruiting now

Conditions studied: Dyslipidemias, Lipid Testing, Myocardial Infarction

In brief

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Key facts

Study ID

NCT06388668

Run by

Montreal Heart Institute

People needed

100

Starts

2024-06-01

Expected to finish

2026-05-01

Last updated by the study team

2025-12-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients ≥18 years old
• Hospitalized at the Cardiac Care Unit for Myocardial Infarction (either NSTEMI or STEMI)
• Lipid panel performed on day 0 of admission
• Willing to provide informed consent

You may not qualify if…

• None

Where it is running

• Montreal Heart Institute — Montreal, Quebec, Canada (enrolling)
• Montreal Heart Institute — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.